TGFB1 and idiopathic pulmonary fibrosis: Clinical study [10] also demonstrated that oxymatrine, the N-oxide analogue of matrine, could significantly reduce serum matrix metalloproteinase-9 (MMP-9) and TGF-β1 level in IPF patients.